Young Hoon Ahn

Electrophilic tuning of the chemoprotective natural product sulforaphane

Sulforaphane [1-isothiocyanato-4-(methylsulfinyl)butane], a naturally occurring isothiocyanate derived from cruciferous vegetables, is a highly potent inducer of phase 2 cytoprotective enzymes and can protect against electrophiles including carcinogens, oxidative stress, and inflammation. The mechanism of action of sulforaphane is believed to involve modifications of critical cysteine residues of Keap1, which lead to stabilization of Nrf2 to activate the antioxidant response element of phase 2 enzymes. However, the dithiocarbamate functional group formed by a reversible reaction between isothiocyanate of sulforaphane and sulfhydryl nucleophiles of Keap1 is kinetically labile, and such modification in intact cells has not yet been demonstrated. Here we designed sulforaphane analogs with replacement of the reactive isothiocyanate by the more gentle electrophilic sulfoxythiocarbamate group that also selectively targets cysteine residues in proteins but forms stable thiocarbamate adducts. Twenty-four sulfoxythiocarbamate analogs were synthesized that retain the structural features important for high potency in sulforaphane analogs: the sulfoxide or keto group and its appropriate distance to electrophilic functional group. Evaluation in various cell lines including hepatoma cells, retinal pigment epithelial cells, and keratinocytes as well as in mouse skin shows that these analogs maintain high potency and efficacy for phase 2 enzyme induction as well as the inhibitory effect on lipopolysaccharide-induced nitric oxide formation like sulforaphane. We further show in living cells that a sulfoxythiocarbamate analog can label Keap1 on several key cysteine residues as well as other cellular proteins offering new insights into the mechanism of chemoprotection.

A Fluorescent Rosamine Compound Selectively Stains Pluripotent Stem Cells

Stem cells, which are capable of self-renewing and differ-entiating into various types of cells, have captured greatinterest as a valuable resource for regenerative medicine anddevelopmental biology research. Technical progress duringthe last decade has enabled the isolation of stem cells from awide range of tissues, their differentiation into specific typesof cells, and the generation of induced pluripotent stem cells(iPSC) from somatic cells. The recent success of patient-specific iPSC generation

Styryl-Based Compounds as Potential in vivo Imaging Agents for β-Amyloid Plaques

A group of styryl‐based neutral compounds has been synthesized in this study for potential use as in vivo imaging agents for β‐amyloid plaques. Of 56 candidates, 14 compounds were found to label β‐amyloid plaques well on Alzheimers disease (AD) human brain sections in vitro. The binding affinity to β‐amyloid fibrils was then determined by measuring the change in fluorescence intensity. Interestingly, we found that a class of quinaldine‐styryl scaffold compounds displays specific binding to β‐amyloid fibrils. A representative compound, STB‐8, was used in ex vivo and in vivo imaging experiments on an AD transgenic mouse model and demonstrated excellent blood–brain barrier (BBB) permeability and specific staining of the AD β‐amyloid plaques.

Development of Neh2-Luciferase Reporter and Its Application for High Throughput Screening and Real-Time Monitoring of Nrf2 Activators

The NF-E2-related factor 2 (Nrf2) is a key transcriptional regulator of antioxidant defense and detoxification. To directly monitor stabilization of Nrf2, we fused its Neh2 domain, responsible for the interaction with its nucleocytoplasmic regulator, Keap1, to firefly luciferase (Neh2-luciferase). We show that Neh2 domain is sufficient for recognition, ubiquitination, and proteasomal degradation of Neh2-luciferase fusion protein. The Neh2-luc reporter system allows direct monitoring of the adaptive response to redox stress and classification of drugs based on the time course of reporter activation. The reporter was used to screen the Spectrum library of 2000 biologically active compounds to identify activators of Nrf2. The most robust and yet nontoxic Nrf2 activators found--nordihydroguaiaretic acid, fisetin, and gedunin--induced astrocyte-dependent neuroprotection from oxidative stress via an Nrf2-dependent mechanism.

Bodipy-diacrylate imaging probes for targeted proteins inside live cells

A bodipy probe was developed for site-specific labeling of tagged proteins inside live cells which displays a large spectral change upon covalent coupling to the designed peptide that contains two pairs of Arg-Cys.

Control of muscle differentiation by a mitochondria-targeted fluorophore.

During muscle differentiation, mitochondria undergo dramatic changes in their morphology and distribution to prepare for the higher rate of energy consumption. By applying a mitochondria-targeted rosamine library in C2C12 myogenesis, we discovered one compound that controls muscle differentiation. When treated to undifferentiated myoblasts, our selected compound, B25, inhibited myotube formation, and when treated to fully differentiated myotubes, it induced fission of multinucleated myotubes into mononucleated fragments. Compared to myoseverin, which is known for inducing myotube fission by destabilizing microtubules, B25 affects neither microtubule stability nor cell cycle. Further investigation identified that B25 induces myotube fission through the activation of NF-kappaB, which is one of the important signaling pathways linked to skeletal muscle differentiation. So far, the use of small-molecule fluorophores is limited in the discovery of labeling agents or sensors. In addition to their potential as a sensor, here we show the application of fluorescent small molecules in the discovery of a bioactive probe that induces a specific cellular response.

Selective Human Serum Albumin Sensor from the Screening of a Fluorescent Rosamine Library

A fluorescent dye library approach for the development of a bioanalyte sensor was sought. The screening of a rosamine dye library against diverse macromolecules led to the discovery of a highly sensitive human serum albumin binder, G13, with approximately 36-fold fluorescence intensity change. G13 showed a highly selective response to HSA over other macromolecules including albumins from other species. The potential use of G13 for the detection of HSA in biofluids is described.

Live cell studies of p300/CBP histone acetyltransferase activity and inhibition

Histone acetyltransferase enzymes (HATs) are important therapeutic targets, but there are few cell‐based assays available for evaluating the pharmacodynamics of HAT inhibitors. Here we present the application of a FRET‐based reporter, Histac, in live‐cell studies of p300/CBP HAT inhibition, by both genetic and pharmacologic disruption. shRNA knockdown of p300/CBP led to increased Histac FRET, thus suggesting a role for p300/CBP in the acetylation of the histone H4 tail. Additionally, we describe a new p300/CBP HAT inhibitor, C107, and show that it can also increase cellular Histac FRET. Taken together, these studies provide a live‐cell strategy for identifying and evaluating p300/CBP inhibitors.

The Binding of Fluorophores to Proteins Depends on the Cellular Environment

Fluorescent small-molecules become extensively used for live-cell imaging, but mainly in the context of labeling conjugates for other protein-binding motifs, such as antibodies.[1] As most fluorescent molecules are flat and hydrophobic, it has generally been believed that these fluorophores may bind to many hydrophobic proteins in cells, without any specificity.[2] This conventional wisdom, however, has not been tested systemically due to the lack of sufficiently diverse dye sources. Recently, we developed a diversity-oriented fluorescence library approach (DOFLA) to use fluorescent dyes to distinguish directly cellular components such as GTP,[3] DNA,[4] RNA,[5] heparin,[6] and organelles.[7] In this system, the diverse structural motifs of each dye molecule in the library endowed target selectivity. From these results, we envisioned that sufficient structural modifications of fluorophore scaffold could lead us to develop probes that label specific proteins from whole proteomes.[8] In addition to our recent finding of a fluorescein derivative labeling glutathione s-transferase,[9] here we report a rosamine derivative that labels tubulin in vitro and a mitochondrial protein in live cells. Previously a fluorescent small molecule capable of detecting differentiated myotubes was discovered from mitochondria-targeted rosamine library.[10, 11, 12] The hallmark of muscle differentiation is the fusion of mono-nucleated myoblasts to multi-nucleated myotubes.[13] During murine C2C12 myogenesis, the fluorescence intensity of one rosamine compound, E26, increased significantly. This myotube selectivity may be achieved by binding to one of the differentiation markers expressed more highly in myotubes; alternatively, the probe may detect other physiological changes after differentiation. When subjected for the further investigation, unfortunately, E26 showed photo-instability under strong and continuous light irradiation (Supplementary Fig. 1 online). The rosamine library compounds were retested under long-term light exposure and we selected two compounds (I25 and I31; Fig. 1) based on high photo-stability and fluorescence response after differentiation (I25: 2.4 ± 0.2, I31: 3.0 ± 0.5 fold increase, N = 3; Supplementary Fig. 2 online). Figure 1 Probes for myogenic differentiation In order to identify protein binders of these compounds, affinity matrices were prepared based on careful SAR studies (Fig. 2a). Affinity pull-down assay is the most conventional method for identification of small-molecule binding proteins.[14] Affinity resins were incubated with myotube lysates and washed with buffer to get rid of non-specific binders. Then, resin-bound proteins were separated by SDS-PAGE and stained with Coomassie blue (Fig. 2b). One enriched protein band at approximately 54 kDa was observed along with several other bands. To determine the specificity of protein binders to these compounds, competition assay was followed. Myotube cell lysate was pre-incubated with 100 µM of I25, I31, rhodamine 123, or rhodamine B before affinity pull-down. Figure 2 Identification of protein-binders in vitro vs. in living cells The strongest band at 54 kDa completely disappeared upon competition with unmodified I25 or I31, but not with rhodamine 123 or rhodamine B, which were included as structurally similar controls. Thus, we concluded that the 54 kDa band was the most convincing binding target protein of the compounds. The band was excised, sequenced, and identified to be tubulin (Supplementary Note 1 online). While affinity pull-down assay identified the major binder to be tubulin, a well-known cytosolic protein, our compounds appeared to be localized to mitochondria in live cells. Affinity-based isolation greatly depends on protein abundace as well as protein binding affinity. Since tubulin is a highly abundant protein in cells (10 ~ 20 µM),[15] despite the intrinsic affinity, its isolation might be an artifact. Therefore, we further explored the endogenus binding protein in the context of live cells. For live-cell investigation, we synthesized a cell-permeable chemical affinity derivative, which has a thiol reactive chloroacetyl group, to enable covalent binding to target proteins (Fig. 2c). The compound is named as CDy2, Compound of Designation yellow 2, following the biological convention of Cluster of Designation (CD) for cell-surface markers. The benefit of the chemical affinity probe is that once it forms a covalent bond with its targets in live cells. Those labeled proteins can be visualized by scanning the SDS-PAGE gel with a fluorescence scanner, even though the proteins are denatured. When applied to myoblasts and myotubes, CDy2 showed a 2.3-fold increase in fluorescence intensity after differentiation (2.3 ± 0.4 fold increase, N = 3; Fig. 2d), which is comparable to the increases observed with I25 and I31. To unveil the endogenus binding protein(s), myoblasts or myotubes were incubated with CDy2 for 1 hour. Labeled lysates were separated by SDS-PAGE and analyzed with a fluorescence scanner (Fig. 2d). Again, a unique fluorescently labeled band was observed around 54 kDa (Fig. 2e). Also, pre-treatment of myotubes with I31 reduced the intensity of CDy2-labeled protein band, indicating effective competition of CDy2 with I31 in live cells (Supplementary Fig. 3b online). To determine the identity of the labeled protein, cell lysates were separated by 2D-gel electrophoresis, and fluorescently labeled spots around 54 kDa were excised and sequenced (Fig. 2f; Supplementary Note 2 online). To our surprise, the major spots were found to be mitochondrial aldehyde dehydrogenase (ALDH2), not tubulin. To validate the binding in live cells, firstly ALDH2 or tubulin was overexpressed in HEK cells. Each protein was tagged with green fluorescent protein (GFP) to distinguish those from the endogenous proteins. Forty-eight hours after transfection, cells were labeled with CDy2 and each lysate was subjected to SDS-PAGE analysis (Fig. 3a); the HEK293 cell line was chosen because of its relatively high transfection efficiency. The result shows that CDy2 labeled ALDH2-GFP, but not tubulin-GFP. Secondly, ALDH2 expression was suppressed by siRNA (Fig. 3b). Upon ALDH2 knock-down, the CDy2-labeled band (54 kDa) was dramatically reduced. These siRNA and overexpression experiments clearly indicate that CDy2 selectively binds to ALDH2 in living cells. However, when treated to cell lysates, CDy2 labeled tubulin instead of ALDH2 (Supplementary Fig. 4d online). Altogether, these results suggest that CDy2 binds to two distinct proteins depending on the experimental environment. Figure 3 Validation of labeled protein identity in living cells In-gel fluorescence analysis showed that CDy2 labels ALDH2 stronger in myotubes over myoblast (Fig. 2e). Interestingly, however, the total amount of ALDH2 remained unchanged before and after differentiation. Thus it was necessary to determine the mechanism of CDy2 selectivity for myotubes. For example, the mitochondrial membrane potential of skeletal muscle is quite high, possibly due to increased energy requirements for muscle contractions;[13] this elevated membrane potential may cause the myotube-selectivity of CDy2. In fact, when cells were fixed with formaldehyde, CDy2 lost its mitochondrial preference, as well as its selectivity for myotubes (Supplementary Fig. 4a online). Further, the mitochondrial membrane potential was disrupted by treating cells with the mitochondrial uncoupler CCCP (carbonyl cyanide 3-chlorophenylhydrazone).[16] Upon pre-treatment with CCCP, the amount of fluorescently labeled protein was significantly reduced (Supplementary Fig. 4c online). These results support the notion that an increase in the mitochondrial membrane potential as a result of myogenesis gives rise to the selectivity of CDy2 for myotubes. Rosamine compounds are derivatives of rhodamine, which have long been used as mitochondrial probes. Their aromatic and cationic properties direct them to mitochondria due to the membrane potential across its bilayer.[17] The rosamine probes are sensitive to the incresed membrane potential after myogenic differentiation. Once localized in mitochondria, they labeled ALDH2 selectively. Although ALDH2 itself is not a differentiation marker, the selectivity to rosamine probes deserves careful consideration. Up until now, it has been generally believed that rhodamine dyes stain the mitochondrial membrane without showing specific interactions with mitochondrial proteins.[18] A cell is a highly ordered structure,[19] where small-molecule localization is precisely controlled based on chemical properties. Once a small molecule is sequestered in an organelle such as mitochondria, its interaction with proteins will be greatly limited within the cellular compartment. In this study, CDy2 showed an apparent binding affinity to tubulin in vitro, but resulted in binding to ALDH2 in live cells. This implies that CDy2 molecules are sequestered in mitochondria rapidly before they have a chance to react with tubulin in the cytoplasm. Elucidating small molecule’s binding protein is the most challenging part of chemical genetics work. Our observations cast important warning that the binding partner should be carefully evaluated in the context of the environmental factors.

Hyaluronan Fragments Promote Inflammation by Down-Regulating the Anti-inflammatory A2a Receptor

The tissue microenvironment plays a critical role in regulating inflammation. Chronic inflammation leads to an influx of inflammatory cells and mediators, extracellular matrix turnover, and increased extracellular adenosine. Low molecular weight (LMW) fragments of hyaluronan (HA), a matrix component, play a critical role in lung inflammation and fibrosis by inducing inflammatory gene expression at the injury site. Adenosine, a crucial negative regulator of inflammation, protects tissues from immune destruction via the adenosine A2a receptor (A2aR). Therefore, these two extracellular products of inflammation play opposing roles in regulating immune responses. As such, we wanted to determine the effect of LMW HA on A2aR function. In this article, we demonstrate that LMW HA causes a rapid, significant, and sustained down-regulation of the A2aR. CD44 was found to be necessary for LMW HA to down-modulate the A2aR as was protein kinase C signaling. We also demonstrate that LMW HA induces A2aR down-regulation during inflammation in vivo, and that this down-regulation can be blocked by treatment with an HA-blocking peptide. Because adenosine plays a critical role in limiting inflammation, our data provide a novel mechanism whereby LMW HA itself may further augment inflammation. By defining the pro- and anti-inflammatory properties of extracellular matrix components, we will be better able to identify specific pharmacologic targets as potential therapies.